πŸ‡ΊπŸ‡Έ FDA
Patent

US 9572883

Oncolytic rhabdovirus

granted A61KA61K35/761A61K35/763

Quick answer

US patent 9572883 (Oncolytic rhabdovirus) held by TURNSTONE LIMITED PARTNERSHIP expires Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNSTONE LIMITED PARTNERSHIP
Grant date
Tue Feb 21 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K35/761, A61K35/763, A61K35/766, A61K35/768